论文部分内容阅读
OBJECTIVE: To investigate the expression and clinical significances of tumor antigen MAGE-D 4,OY-TE S-1 and NY-SA R-35 in glioma and evaluate these three antigens as prognositic marker and immunotherapeutic targets for glioma.